Depression Clinical Trial
Official title:
Role of Online Discussion Forums in Unguided Internet-Delivered Cognitive Behavioural Therapy for Canadian Public Safety Personnel: A Randomized Trial
Verified date | August 2023 |
Source | University of Regina |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a randomized trial designed to evaluate unguided (i.e., purely self-help), transdiagnostic internet-delivered cognitive behavioural therapy tailored specifically for public safety personnel both with and without a built-in online discussion forum.
Status | Completed |
Enrollment | 107 |
Est. completion date | February 28, 2023 |
Est. primary completion date | February 28, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria - At least 18 years of age - Current or former public safety personnel (or public safety personnel trainee) - Residing in Canada at time of enrollment - Has regular access to the internet Exclusion Criteria - Not 18 years of age or older - Not a current or former public safety personnel (or public safety personnel trainee) - Not residing in Canada at time of enrollment - Does not have regular access to the internet |
Country | Name | City | State |
---|---|---|---|
Canada | Department of Psychology and Collaborative Centre for Justice and Safety | Regina | Saskatchewan |
Canada | University of Regina | Regina | Saskatchewan |
Lead Sponsor | Collaborator |
---|---|
University of Regina | Government of Canada |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Depression | Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9) is a commonly used measure of depression that includes an item to measure suicidality (Kroenke et al., 2001). It has demonstrated excellent psychometric properties in many studies (e.g., Cameron et al., 2008; Kroenke et al., 2001, 2010). Its nine items are rated on a four-point Likert scale from 0 (not at all) to 3 (nearly every day) for a total score ranging from 0 to 27. Traditionally, a score of 10 or greater has been considered indicative of a likely diagnosis of major depressive disorder on the PHQ-9 (Manea et al., 2012). A change in score of six points has been identified as a reliable change index (National Collaborating Centre for Mental Health, 2019). | Baseline, 8 weeks, 20 weeks | |
Primary | Change in Anxiety | Generalized Anxiety Disorder-7. The Generalized Anxiety Disorder-7 (GAD-7) is a seven-item measure of generalized anxiety symptoms. Like the PHQ-9, its items are rated on a four-point Likert scale from 0 (not at all) to 3 (nearly every day). Possible total scores range from 0 to 21. Research shows that the GAD-7 has strong psychometric properties, and a score of 10 or greater can be used to indicate a likely diagnosis of generalized anxiety disorder (Kroenke et al., 2010; Spitzer et al., 2006). Following the precedent of other ICBT researchers, a change in score of five points or more will be considered clinically significant (Titov et al., 2017). | Baseline, 8 weeks, 20 weeks | |
Primary | Change in Posttraumatic Stress | PTSD Checklist for DSM-5. The PTSD Checklist for DSM-5 (PCL-5) is a common measure of PTSD that was updated following the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; (American Psychiatric Association, 2013; Blevins et al., 2015; Weathers et al., 2013). It includes 20 items that are rated on a five-point Likert scale from 0 (not at all) to 4 (extremely), for a total score between 0 and 80. Several research groups have suggested that a score of 33 or greater indicates a likely diagnosis of PTSD (Bovin et al., 2016; Wortmann et al., 2016). A change in score of 10 points or more is considered a reliable change on the PCL-5 (Byllesby et al., 2019). At baseline (but not at later timepoints), the investigators will administer a version of the PCL-5 that includes five additional questions about the nature of the potentially psychologically traumatic event that a respondent experienced (Weathers et al., 2013). | Baseline, 8 weeks, 20 weeks | |
Secondary | Change in Functional Impairment | Sheehan Disability Scale. The Sheehan Disability Scale (SDS) is a three-item measure of functional impairment that has demonstrated good psychometric properties (Sheehan, 1983). Each item inquires about the degree to which symptoms have disrupted a different domain in a respondent's life (i.e., work/school, social life, and family life/home responsibilities). Response options range from 1 (not at all) to 10 (extremely) on a visual analog scale. The items can be interpreted individually or summed for a total score between 0 and 30. There is no clinical cut-off score.
Of note, although we originally planned to administer the SDS, we ultimately removed it from our outcome measures because we were unable obtain permission to use it. |
Baseline, 8 weeks, 20 weeks | |
Secondary | Change in Resilience | Brief Resilience Scale. The Brief Resilience Scale (BRS) is a six-item self-report measure of resilience that has demonstrated good reliability and validity (Leontjevas et al., 2014; Smith et al., 2008; Windle et al., 2011). Responses are selected using a five-point Likert scale from 1 (strongly disagree) to 5 (strongly agree), and a higher mean score indicates greater resilience. Three of the items are reverse-scored. | Baseline, 8 weeks, 20 weeks | |
Secondary | Change in Wellbeing and Flourishing | Flourishing Scale. The Flourishing Scale (FS) is an eight-item self-report measure of flourishing across several important domains of human functioning (e.g., positive relationships, meaning and purpose, feelings of competence). The FS has demonstrated good psychometric properties and correlates strongly with other measures of wellbeing (Diener et al., 2009, 2010). Responses are selected using a seven-point Likert scale from 1 (strongly disagree) to 7 (strongly agree) for a total score between 8 and 56. It is worth noting that the FS was formerly called the Psychological Well-Being Scale, but its name was changed to reflect its measurement of a construct broader than wellbeing as it is commonly defined (Diener et al., 2010). A higher score indicates a higher degree of flourishing across various facets of human life. | Baseline, 8 weeks, 20 weeks | |
Secondary | Change in Healthcare Use | Healthcare Use Questionnaires. The Healthcare Use Questionnaires will be administered during eligibility screening, and a different version of this questionnaire will be administered at eight weeks and 20 weeks. Both versions will include a series of questions related to participants' past and current use of healthcare services, particularly for mental health challenges. | Baseline, 8 weeks, 20 weeks | |
Secondary | Treatment Satisfaction | Treatment Satisfaction Questionnaire. The Treatment Satisfaction Questionnaire is a brief bespoke questionnaire assessing participants' treatment satisfaction. Participants assigned to the ICBT + Peer Support Forum condition will be presented with an expanded version of this questionnaire that will include questions assessing their satisfaction and experiences with the forum. | 8 weeks | |
Secondary | Patient-Program Alliance | Adapted Session Rating Scale. The Session Rating Scale (SRS) is a four-item scale originally designed to measure clients' perceptions of the working alliance between themselves and their therapists (Miller et al., 2000). The items assess perceptions of bond, goal agreement, task agreement, and overall working alliance. They are rated on a seven-point Likert scale from 0 (absolutely disagree) to 6 (absolutely agree). The SRS has demonstrated good psychometric properties (Campbell & Hemsley, 2009; Duncan et al., 2003). Cavanagh and colleagues (2018) adapted the SRS to measure patient-program alliance in an ICBT study. The investigators will use their adapted version of the SRS with a slight wording change to each item, such that the measure refers to the Self-Guided PSP Wellbeing Course by name. | 8 weeks | |
Secondary | Program Use | Program Use Questionnaire. This is a two-item bespoke questionnaire assessing the degree to which participants engaged with treatment content and the degree to which they found it helpful during the course of treatment. Participants assigned to the ICBT + Peer Support Forum condition will receive an additional three items assessing the degree to which they engaged with the forum and the degree to which they found it helpful. | 2 weeks, 4 weeks, 6 weeks, 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |